acetazolamide has been researched along with Thyrotoxicosis in 2 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Interestingly, hypoPP is caused by both mutations affecting nearby codons as well as the change of an arginine into another amino acid." | 1.32 | New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis. ( Eymard, B; Fontaine, B; Fournier, E; Hainque, B; Kuntzer, T; Laforet, P; Ochsner, F; Sternberg, D; Vicart, S, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vicart, S | 1 |
| Sternberg, D | 1 |
| Fournier, E | 1 |
| Ochsner, F | 1 |
| Laforet, P | 1 |
| Kuntzer, T | 1 |
| Eymard, B | 1 |
| Hainque, B | 1 |
| Fontaine, B | 1 |
| Ghosh, D | 1 |
| Trivedi, N | 1 |
| Kohli, A | 1 |
| Mithal, A | 1 |
2 other studies available for acetazolamide and Thyrotoxicosis
| Article | Year |
|---|---|
New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis.
Topics: Acetazolamide; Action Potentials; Adolescent; Adrenal Cortex Hormones; Adult; Amino Acid Substitutio | 2004 |
Hyperkalemic periodic paralysis associated with thyrotoxicosis.
Topics: Acetazolamide; Adult; Carbimazole; Electromyography; Humans; Hyperkalemia; Male; Paralysis; Thyrotox | 1993 |